The mechanism of the action of xanthocillin X monomethylether (XME) on multiplication of Newcastle disease virus (NDV) in cultured cells was studied. The inhibitory effect of XMEwas exerted whenever the antibiotic (15/^g/ml) was added during the viral one-step growth cycle, and the effect could be reversed after removal of the antibiotic by washing. A lag period of approximately 5 hours was observed before the restoration of hemagglutinin synthesis had occurred. Pretreatment of host cells with XME for 7 hours and subsequent removal of the antibiotic did not affect velocity and yield of virus production. XME completely inhibited protein synthesis in both virus infected and mock-infected cells, however total actinomycin D-insensitive RNA synthesis was found to be practically the same in antibiotic-treated cells as in the control. Actinomycin D-insensitive RNAsynthesized in the presence of XME was more heterogeneous than the control using methylated albuminkieselguhr (MAK) column chromatography. Antiviral activity of XME was compared with that of other antibiotics known to be inhibitors of protein synthesis. XME was found to be one of the best inhibitors among all compounds tested, due to its low cytotoxicity and low effective concentration in agar-diffusion plaque-inhibition tests.
During the course of an antiviral antibiotic screening program, mycelial acetone extract of two soil fungi was found to exert a remarkable antiviral activity on both RNAand DNAviruses using the agar-diffusion plaque-inhibition method. Three active principles were isolated in crystalline form and named xanthocillin X mono-and dimethylether and methoxy-xanthocillin X dimethylether (XME, XDE and XTE)X)5 respectively.
Their structure was determined spectrometrically and found to be as shown in Fig. 1 (manuscript in preparation). They have unique structures among fungal metabolites ; each one possessing two isonitrile groups. A preliminary study on the action of these three antibiotics on multiplication of NDVshowed that XMEexerted the most pronounced inhibitory effect using both plate and tube assay methods Actinomycin D-insensitive RNAsynthesis was observed in the presence of XMEand the velocity was nearly the same as in the control when the antibiotic was added 4 hours after infection.
This result is in good accordance with the effect of other inhibitors of protein synthesis such as puromycin and 5-fluorophenylalanine3'4).
However, the elution profile of the RNA,synthesized in the presence of XME, was found to be more heterogeneous than the control using MAK column chromatography. Antiviral activity of XME,which was found to be based on inhibition of protein synthesis, was compared with that of other protein inhibitors, employing the agardiffusion plaque-inhibition method.
Materials and Methods Virus-cell system. The Miyadera strain of NDVand primary cultures of CEF were employed,and the proliferation methodswere the sameas reported previously1).
Infection with NDV.Con fluent monolayers of CEF in test tubes (10x200 mm)or Petri dishes (90 mmin diameter) were washed twice with precooled (5°C) medium. NDV was added at an input multiplicity of 50 PFU/cell and allowed to be adsorbed at 5°C for 2 hours. Unadsorbed virus was removed by washing the cell sheets twice with prewarmed (38.5°C) medium. The infected cells were re-fed with fresh prewarmed medium (1 ml/tube or 10ml/dish) and incubated at 38.5°C (0 time). The same run was carried out with mock-infected controls. Titration of virus production. Viral growth was followed by titration of hemagglutinin units (HAU) and/or PFU after three cycles of freezing-and-thawing in a dry ice-acetone bath2).
Examination of antiviral activity by agar-diffusion plaque-inhibition method. According to the method of Herrmannet al.5), con fluent monolayers of CEFin Petri dishes were infected with NDVto form about 3,000 plaques/dish. Paper disks (Toyo Roshi Co., Tokyo, Japan) impregnated with antibiotic solutions were placed on hardened overlayers of soft agar medium. After a 2-day incubation at 38.5°C, the diameters of the cytotoxic zones caused by the drugs and the plaque-free antiviral zones were measured6). Labeling with uC-protein hydrolysates. Virus-infected and mock-infected cell sheets in test tubes were washed twice with prewarmed medium deprived of lactoalbumin hydrolysate and re-fed with fresh medium (1 ml/tube). After a 30-minute incubation period at 38.5°C, the mediumwas replaced with the mediumfree of lactoalbumin hydrolysate and containing XME(15 /ig/ml) as well as 14C-protein hydrolysates (0.5 juC/ml, 54 mC/ mAtomcarbon). They were further incubated at 38.5°C. At the times indicated, bovine serum albumin (200^g/ml) and cold 10% trichloroacetic acid (TCA) were added after infection and growth were performed with the medium free of phosphate. XME(15 jugj ml) and actinomycin D (2 jug/mY) were added to infected cell cultures in Petri dishes or test tubes and carrier-free 32P-phosphate (50~100 /zC/ml) was added after a 1-hour treatment with the antibiotics.
Incorporation of radioactivity was stopped by addition of ethylenediamine tetraacetic acid (EDTA) (10~2 m) and sodium dodecylsulfate (SDS) (1 %) or by chilling in an ice bath. For the measurement of total incorporation of radioactivity into RNA, cells and medium in duplicate tubes were fractionated by the SchmidtThannhauser method7) and radioactivity in the RNAfraction was counted after drying on metal planchets. Nucleic acids were extracted by shaking twice for 3 minutes with an equal volume of phenol-saturated 0.05M phosphate buffer (pH 6.7). Two volumes of ethanol were added to the aqueous layers after addition of nucleic acids prepared from chick embryos by the SDS-phenol method as carriers. After standing at -20°C overnight, precipitates were collected by centrifugation. MAK column chromatography.
MAK columns were prepared by the method of Sueoka and Cheng8). Nucleic acids labeled with 32P, prepared as described, above were dissolved in 0.1 MNaCl-0.05M phosphate buffer (pH 6.7) and loaded on the column. The absorbed nucleic acids were washed with 100 ml 0.2 M phosphate buffer and allowed to stand at 5°C for more than 10 hours. Standing at 5°C or at room temperature makes possible the separation of 18S and 28S ribosomal RNA, but 5°C is more recommendable in order to. avoid a degradation during standing (manuscript in preparation). Elution of nucleic acids was carried out using linear gradient indicated and in each case elution was followed by measuring radioactivity and optical density at 260 mju (OD260m^).
Counting of radioactivity. Radioactivity of UC and S2P in each sample was counted by drying an aliquot on a metal planchet and using a gas flow counter Aloka Model PS-3 or SC-7 (Japan Radiotelegraph Co., Tokyo, Japan). 
Results
Effect of addition time on NDVgrowth. Con fluent monolayers of CEF in test tubes were infected with NDVat an input multiplicity of 50 PFU/cell. Viral growth was followed by titration of HAUafter a 2-hour adsorption period. XME(15 jug/ml) was added at the times indicated in order to determine the relationship between time of addition and inhibitory activity on viral growth. XMEdisplayed its activity whenever it was added during the viral one-step growth cycle. Complete inhibition of hemagglutinin (HA) synthesis was found already 1 hour after addition of the antibiotic (Fig. 2) .
Reversibility of the inhibitory action of XME, XME (15 /zg/inl) was added at zero hour and removed again by washing cell sheets in test tubes after various periods of treatment in order to examine the recovery of HA synthesis after its inhibition by the antibiotic (Fig. 3) (Fig. 4) Con fluent monolayers of CEFin test tubes were infected with NDV (50PFU/cell), and XME (15 jug/ml) was added at 0, 1, 4 and 6hours after infection.
NDV multiplication in duplicate tubes was followed by titration of HAUand was compared with that in the absence of the antibiotic (negative control).
fhr. , Positive control < J * y-*-lf-** 0 5 10 15 20 hrs. Fig. 3 . Reversibility of the inhibitory action of XME (15jug/ml) on NDV growth after removal of XME after infection.
Cell sheets in test tubes were infected with NDV (50PFU/cell) and XME was added at zero hour.
The antibiotic was removed by washing cell sheets twice at 1, 4 and 7 hours after application. Viral growth in the presence (positive control) and in the absence (negative control) of the antibiotic throughout the experiment was also tested. Viral multiplication was determined by titration of HAU and checked by PFU counting at 22 hours. . Effect of pretreatment of cultured CEF with XME(15Mg/ml) on NDVmultiplication.
Con fluent monolayers in test tubes were pretreated with XME for 7 hours and the antibiotic was removed at the time of infection (50 PFU/cell). Viral growth in the pretreated cells in the absence (1) and presence (3) of the antibiotic throughout the experiment was followed by HAUtitration and was compared with that in cells mock-treated with XME(2). . Protein synthesis in NDV-infected and mockinfected cells in the presence and absence of XME (15 jug/ml) was determined by measuring the incorporation of 14C-protein hydrolysates into acid-insoluble fraction. XME and protein hydrolysates were added at 5 hours after a 30-minute starvation for amino acids in the lactoalbumin hydrolysate-free medium.
At the times indicated mediumand cells in duplicate tubes were frozen and thawed in a dry ice-acetone bath three times, and 10 % TCA-insoluble radioactivity held on Millipore filters was counted.
. 6 7 8 9 5 6 7 8 there was a complete inhibition of protein synthesis (Fig. 6) . The total actinomycin D-insensitive viral RNAsynthesis of XME-treated cells was nearly equal to that of the controls without XME (Fig. 7) . Wilson and LoGerfo4) and Scholtissek and Rott3) reported the same effect for puromycin and 5-fluorophenylalanine.
The viral RNAsynthesized in the presence of actinomycin D and XMEwas analyzed on MAK column. Carrier-free 32P (50juC/mY) was added after a 1-hour treatment with actinomycin D (2 //g/ml) and XME(15 #g/ml) at a time when cellular nucleic acids and cellular and viral protein synthesis were almost completely inhibited. Pulse labeling was carried out for 5 hours. Newly synthesized and 32P-labeled viral RNAwere extracted by SDS-phenol method and analyzed by passing through MAK column. Results of a representative test are shown in Fig. 8 . Total incorporation of radioactivity into the RNAfraction was nearly equal for XME-treated cells and the control (Fig. 7) . However the radioactivity eluted at the position of mature NDV-RNA (after 28S ribosomal RNA, unpublished data) was about one-third that of the control when infected cells were treated with XME. The residual radioactivity was found to be eluted at a lower salt concentration (ca. 0.4m). Antiviral activity of antibiotics which inhibit protein synthesis. Many antibiotics have been reported to inhibit protein synthesis in bacteria and/ or animal cells, and some of them show specificity for either bacteria or animal cells. The mechanism of their action was reviewed by Tanaka12?13). XMEwas found to be a potent inhibitor of protein synthesis (Fig. 6) All of them were also inactive on NDV growth in the agar-diffusion method and they displayed no cytotoxicity for cultured cells at the highest concentration examined (4 mg/ml).
Discussion XME showed inhibitory action on protein synthesis in NDV-infected and mockinfected cells but had only a slight effect on actinomycin D-insensitive RNA synthesis. An accumulation of precursors of ribosomal RNA was observed in cultured cells in the presence of XME, and the antibiotic inhibited the conversion of the precursors to mature ribosomal RNA's requiring new synthesis of protein(s)18) (manuscript in preparation). These results may indicate that the inhibition of viral growth due to XME is a result of cessation of protein synthesis. However, a determination whether or not the inhibition of protein synthesis is the primary step of the action of XME requires further studies including an examination with cell-free protein synthesizing systems. The inhibitory action was displayed whenever the antibiotic was added during the viral one-step growth cycle (Fig. 1) , and this may be a fact to be taken into consideration that the antiviral activity may be the result of the inhibition of protein synthesis. (Fig. 7) . MAK column chromatography of the newly synthesized actinomycin D-insensitive RNA revealed that the RNA, synthesized in the presence of XME, was more heterogeneous and the radioactivity eluted at the position of mature NDV-RNA was less than that of the control and the residual radioactivity was found to be eluted at a lower salt concentration (Fig. 8) . This may suggest the requirement of new or continuous synthesis of protein for completion of the lengthening of the NDV-RNA chain. However, another possibility exists that NDV-RNA synthesized in the presence of XME may be unstable and may degradate during extraction procedures. Studies in this direction are in progress. XME was found to be a potent inhibitor of protein synthesis (Fig. 6) , and its antiviral activity was compared with that of other antibiotics known to be protein inhibitors (Table  1) .
Among a number of antibiotics tested, XME, cycloheximide, puromycin and blasticidin S showed remarkable antiviral activity at concentrations where they displayed no cytotoxicity for cultured cells by the agar-diffusion method.
The activity of XME and cycloheximide was superior to that of puromycin and blasticidin S due to their low cytotoxicity.
Tetracycline and a mixture of mikamycin A and B (85: 15) also displayed antiviral activity, but they were very toxic for cultured cells at effective concentrations.
Chloramphenicol, kanamycin, fusidic acid, helvolinic acid, bottromycin, streptomycin and lincomycin had no antiviral and cytotoxic effect at the highest concentration tested (4 mg/ml).
This may be expected taking into consideration of their specificity of action on bacterial protein synthesizing systems. Mikamycin A and B also have the same specificity of action12) and they were ineffective on viral growth when administered individually.
However, a synergism was observed and a mixture of mikamycin A and B (85 : 15) exerted both cytotoxicity and antiviral activity at 31.3^g/ml. This synergism of mikamycin A and B is also known to occur in the case of the inhibitory effect on bacterial growth17). Synergism in the antiviral and cytotoxic effects was more than 250-fold, a value far higher than synergism related to antibacterial activity.
